Our Director, George Papadopoulos, authored the ISPOR, Research Roundup in the September-October 2020 Edition of the Value & Outcomes Spotlight.
The articles featured in this issue’s Research Round-Up look at the current state of real-world evidence (RWE). Real-world data (RWD) and RWE are playing an increasing role in healthcare decisions. The healthcare community is using these data to support coverage decisions and to develop guidelines and decision support tools for use in clinical practice, while developers of pharmaceuticals are using RWD and RWE to support clinical trial designs and observational studies to generate innovative and new treatments. 5 research papers have been identified that encapsulate these characteristics and are worth reading.
ISPOR | September/October 2020 Value & Outcomes Spotlight, RESEARCH ROUNDUP
Section Editor: George Papadopoulos.
Read the full article: Research Roundup, Using Real-World Evidence in Healthcare Decisions.
About the author:
George Papadopoulos, Partner and Director at Lucid Health Consulting. George is a Health Economist, Pricing and Reimbursement and Strategic Market Access Expert with over 25 years in the healthcare industry in both Australia and USA. An experienced key speaker and commentator, his current leadership roles include chairman of ARCS Australia and Lecturer at UNSW, Pharmaceutical Medicine.